Stay updated with breaking news from Use Authorisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
Commending the government for its efforts to increase the vaccine availability in the country for achieving effective protection against COVID-19, the Indian pharma giant has said its discussions with Moderna on the COVID-19 booster vaccine are nearing finalisation and for that, they are seeking the "partnership and support of the government to make this programme successful".
Cipla has requested the government for indemnification & exemptions from price capping, bridging trials, and basic customs duty to bring Moderna's COVID vaccine
Read more about Cipla says close to committing $1 billion to Moderna for booster vaccine on Business Standard. The company has further requested for the government's assurance that no price capping would apply for imported vaccines to be provided through private hospitals
Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19 -- The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19 -- Accurate, reliable and early detection of SARS-CoV-2 in potentially exposed individuals can help limit the spread of disease PLEASANTON, Calif., May 18, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its ...